Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

PURPOSE: Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diagnosed multiple myeloma (NDMM). All studies had PF...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: McCarthy, Philip L., Holstein, Sarah A., Petrucci, Maria Teresa, Richardson, Paul G., Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C., Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D., Palumbo, Antonio, Attal, Michel
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652871/
https://ncbi.nlm.nih.gov/pubmed/28742454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.72.6679
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares